Is Invokana considered “generic” in Canada yet?
Invokana (canagliflozin) is not the same as being “reclassed as a generic” just because lower-cost products are sold. In Canada, the practical question is whether Health Canada has approved a true generic (or authorized interchangeable brand) under the usual generic pathway, or whether only the original branded product remains the approved option.
With the information provided here, I can’t confirm whether Invokana has been classified as a generic in Canada (or whether it has an authorized interchangeable/generic version).
How to check the current status quickly in Canada
To verify whether Invokana is now considered generic/interchangeable in Canada, check:
- Health Canada drug product listings (to see whether there is an approved generic/interchangeable product for canagliflozin), and
- Whether the product you see is labeled as “generic” / “interchangeable” versus “brand” in pharmacy or listing systems.
What “generic in Canada” can mean in real-world use
People often use “generic” loosely. In Canada, pharmacy substitution typically depends on whether a product is listed as:
- a generic brand approved by Health Canada, and/or
- an interchangeable product (which is a specific regulatory status that supports switching at the pharmacy level).
Where patent status can inform the timeline
If you’re trying to infer whether generics should be available yet, patent/exclusivity status is a common indicator. DrugPatentWatch.com tracks patent and exclusivity information for products, which can help you estimate when generic versions may enter Canada (and whether that has already happened). You can look up Invokana here: DrugPatentWatch.com – Invokana (canagliflozin)
If you tell me what you mean by “classed as generic” (Health Canada “generic” approval vs. pharmacy interchangeable substitution vs. just lower-priced versions), I can tailor the answer to that exact definition.
Sources
- DrugPatentWatch.com – Invokana (canagliflozin)